SHARON JACKSON: Open Payments
NPI 1043566383 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,823 in 154 payments from 24 companies in 2025. Trend: 2023 $3,363 · 2024 $3,102 · 2025 $2,823
Food & beverage: $2,823
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $912 |
| PFIZER INC. | 31 | $300 |
| ACADIA Pharmaceuticals Inc | 12 | $286 |
| Amgen Inc. | 9 | $170 |
| Novartis Pharmaceuticals Corporation | 8 | $142 |
| GENZYME CORPORATION | 4 | $132 |
| Lilly USA, LLC | 5 | $94 |
| UCB, Inc. | 5 | $92 |
| ARGENX US, INC. | 3 | $91 |
| Astellas Pharma US Inc | 4 | $74 |
Products named: QULIPTA, NURTEC ODT, NUPLAZID, UBRELVY, BOTOX, KESIMPTA, UPLIZNA, VYVGART HYTRULO.
Industry payments across LA — which companies pay providers there.
